INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

77,304 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
SB
Shardelow Bianca B.VP, Controller & CAO
CXTCrane NXT, Co.
Option exercise
M—
355 sh
Apr 20, 2026Apr 22, 2026
Page 1093 of 1933
← PrevNext →
traded Apr 20, 2026
+2d
SEC Form 4

Evidence

13
SB
Shardelow Bianca B.VP, Controller & CAO
CXTCrane NXT, Co.
Option exercise
M—
355 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

13
RJ
Russell Heather JEVP, Chief Legal Officer
TRUTransUnion
Open-market sale · 10b5-1 plan
SELL$159K
1,983 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$31K
500 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

13
WA
Wilbur Maria Cristina AlapagDirector
AMRZAmrize Ltd
Tax withholding
F$11K
190 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

13
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$212K
9,200 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

13
AR
Agnew Julie RDirector
CFFIC & F FINANCIAL CORP
Grant or award
A—
450 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
7,714 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
NL
Novacek Jorie LSVP, Controller
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,151
5 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
ON
Olmstead NathanSVP and CFO
PENGPenguin Solutions, Inc.
Tax withholding
F$70K
2,605 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
NG
Necastro Timothy GPresident & CEO
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$19K
74 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$177K
5,235 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$184K
5,000 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
PM
Pelkowski Julie MarieEVP & CFO
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$3,044
12 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
SP
Srinivasa ParthasarathyEVP, Chief Information Officer
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$2,812
11 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
9,463 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

12
SS
Shine SarahExecutive Vice President
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$3,917
15 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
CC
Cook CodyExecutive Vice President
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,867
7 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

12
DS
Dugan SeanExecutive Vice President
ERIEERIE INDEMNITY CO
Other acquisition or disposition
J$1,456
6 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

11
DN
Debbi NirDirector, President
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$273
8 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

11
HJ
Hogan Michael JamesChief Business Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$30K
500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

10
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
738 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC Form 4

Evidence

10
FA
Fang AndyDirector
DASHDoorDash, Inc.
Grant or award
A—
11.2K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

10
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
4,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
67.1K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
115.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
HH
Hutchins Glenn HDirector
CRWVCoreWeave, Inc.
Grant or award
A$7,829
67 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
LF
Lizzul Paul F.Chief Medical Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
29.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
YL
You Harry L.Director
AVGOBroadcom Inc.
Grant or award
A—
864 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
2,321 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
NP
Nutz PeterEVP/ Chief Credit Officer
BCALCalifornia BanCorp \ CA
Tax withholding
F$2,683
143 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
17.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
MM
Marquet MagdaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
16.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
6,030 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

9
JR
Jain RitaDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
8,015 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence